Skip to main content
. 2019 Apr 15;22(6):1183–1192. doi: 10.1007/s10120-019-00965-5

Fig. 1.

Fig. 1

HAS samples with different HAS cell component percentages and different AFP immunohistochemical reactivity scores. a 100% HAS cells; b 50% HAS cells, with a classic rich cytoplasmic glycogen content and transparent bodies; c 25% HAS cells; d 10% HAS cells; e strong tumour staining; f weak tumour staining